Stock Earnings

Question 1

What are Belle Isle Corp's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Livzon Pharmaceutical Group Inc. has a total asset of $24,455, Net profit of $2,061

Question 2

What are the key financial ratios for BILSU?

Accepted Answer

Livzon Pharmaceutical Group Inc.'s Current ratio is 2.3, has a Net margin is 17.44, sales per share of $12.83.

Question 3

How is Belle Isle Corp's revenue broken down by segment or geography?

Accepted Answer

Livzon Pharmaceutical Group Inc. largest revenue segment is Chemical Drug Preparations, at a revenue of 6,119,280,577 in the most earnings release.For geography, China is the primary market for Livzon Pharmaceutical Group Inc., at a revenue of 9,976,999,763.

Question 4

Is Belle Isle Corp profitable?

Accepted Answer

yes, according to the latest financial statements, Livzon Pharmaceutical Group Inc. has a net profit of $2,061

Question 5

Does Belle Isle Corp have any liabilities?

Accepted Answer

yes, Livzon Pharmaceutical Group Inc. has liability of 10,593

Question 6

How many outstanding shares for Belle Isle Corp?

Accepted Answer

Livzon Pharmaceutical Group Inc. has a total outstanding shares of 903.64

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	11,846	11,812	12,430	12,629	12,063	10,520
Revenue Growth (YoY)	0%	-5%	-2%	5%	15%	12%
Cost of Revenue	4,191	4,157	4,774	4,577	4,309	3,744
Gross Profit	7,654	7,654	7,655	8,051	7,754	6,777
Selling, General & Admin	4,007	3,932	4,322	4,606	4,601	3,791
Research & Development	982	931	973	1,208	1,066	827
Operating Expenses	4,982	4,912	5,551	5,945	5,634	4,531
Other Non Operating Income (Expenses)	-40	-33	-32	-6	-15	-6
Pretax Income	2,999	2,806	2,382	2,330	2,245	2,489
Income Tax Expense	510	501	485	374	293	358
Net Income	2,142	2,061	1,953	1,909	1,775	1,715
Net Income Growth	6%	6%	2%	8%	4%	32%
Shares Outstanding (Diluted)	893.11	920.35	930.3	935.98	934.57	939
Shares Change (YoY)	-4%	-1%	-1%	0%	0%	0%
EPS (Diluted)	2.38	2.23	2.1	2.04	1.9	1.83
EPS Growth	9%	7%	3%	7%	4%	32%
Free Cash Flow	2,536	2,408	2,428	1,832	593	1,513
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	64.61%	64.79%	61.58%	63.75%	64.27%	64.42%
Operating Margin	22.54%	23.21%	16.91%	16.67%	17.56%	21.34%
Profit Margin	18.08%	17.44%	15.71%	15.11%	14.71%	16.3%
Free Cash Flow Margin	21.4%	20.38%	19.53%	14.5%	4.91%	14.38%
EBITDA	--	2,928	2,559	2,413	2,289	2,377
EBITDA Margin	--	24.78%	20.58%	19.1%	18.97%	22.59%
D&A For EBITDA	--	186	456	307	170	131
EBIT	2,671	2,742	2,103	2,106	2,119	2,246
EBIT Margin	22.54%	23.21%	16.91%	16.67%	17.56%	21.34%
Effective Tax Rate	17%	17.85%	20.36%	16.05%	13.05%	14.38%

Belle Isle Corp (BILSU) Financial

BILSU Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is BILSU?

BILSU Income

Follow-Up Questions